Nicola Valeri
About
Nicola Valeri is a scholar working on Cancer Research, Oncology and Molecular Biology.
According to data from OpenAlex, Nicola Valeri has authored 88 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cancer Research, 36 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Nicola Valeri's work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (22 papers) and Gastric Cancer Management and Outcomes (21 papers). Nicola Valeri is often cited by papers focused on MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (22 papers) and Gastric Cancer Management and Outcomes (21 papers). Nicola Valeri collaborates with scholars based in United Kingdom, Italy and United States. Nicola Valeri's co-authors include Carlo M. Croce, Chiara Braconi, Andrea Lampis, Gerard J. Nuovo, Tushar Patel, Jens C. Hahne, Margherita Ratti, Nianyuan Huang, Francesca Lovat and Takayuki Kogure and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.
In The Last Decade
Nicola Valeri
83 papers receiving 3.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nicola Valeri United Kingdom | 28 | 2.2k | 2.1k | 883 | 830 | 710 | 88 | 3.9k | ||
| Chiara Braconi United Kingdom | 29 | 2.3k 1.0× | 2.2k 1.0× | 1.3k 1.4× | 766 0.9× | 1.2k 1.7× | 83 | 4.4k | ||
| Hideaki Bando Japan | 31 | 1.3k 0.6× | 799 0.4× | 1.1k 1.2× | 2.0k 2.4× | 591 0.8× | 205 | 3.6k | ||
| Philippe Tanière United Kingdom | 29 | 1.0k 0.5× | 497 0.2× | 824 0.9× | 1.1k 1.4× | 618 0.9× | 94 | 2.6k | ||
| Shunsuke Kato Japan | 27 | 2.5k 1.1× | 1.2k 0.6× | 762 0.9× | 2.6k 3.1× | 447 0.6× | 102 | 4.4k | ||
| Ryo Miyahara Japan | 35 | 1.1k 0.5× | 591 0.3× | 1.4k 1.6× | 1.5k 1.8× | 646 0.9× | 101 | 3.3k | ||
| Hitoshi Kawamata Japan | 29 | 1.1k 0.5× | 548 0.3× | 688 0.8× | 1.2k 1.5× | 682 1.0× | 131 | 2.9k | ||
| Andreas Karameris Greece | 27 | 868 0.4× | 474 0.2× | 711 0.8× | 738 0.9× | 630 0.9× | 119 | 2.5k | ||
| Seiji Satoh Japan | 32 | 1.8k 0.8× | 439 0.2× | 1.4k 1.6× | 917 1.1× | 1.3k 1.9× | 76 | 4.2k | ||
| Andrew Ruszkiewicz Australia | 32 | 1.1k 0.5× | 551 0.3× | 574 0.7× | 1.3k 1.6× | 636 0.9× | 103 | 3.0k | ||
| Adam E. Frampton United Kingdom | 33 | 1.6k 0.7× | 1.4k 0.7× | 358 0.4× | 1.1k 1.4× | 546 0.8× | 134 | 3.0k |
Countries citing papers authored by Nicola Valeri
Since
Specialization
Citations
This map shows the geographic impact of Nicola Valeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Valeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Valeri more than expected).
Fields of papers citing papers by Nicola Valeri
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nicola Valeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Valeri. The network helps show where Nicola Valeri may publish in the future.
Co-authorship network of co-authors of Nicola Valeri
This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Valeri. A scholar is included among the top collaborators of Nicola Valeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Valeri. Nicola Valeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Oliveira, Érica A., Javier Fernández-Mateos, George D. Cresswell, et al.. (2025). Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm. Cancer Research. 85(15). 2921–2938.
2.
Al-Batran, S-E., Zev A. Wainberg, Woo Jin Hyung, et al.. (2025). LBA81 Final overall survival (OS) and the association of pathological outcomes with event-free survival (EFS) in MATTERHORN: A randomised, phase III study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric / gastroesophageal junction (G / GEJ) adenocarcinoma. Annals of Oncology. 36. S1623–S1624.
3.
Rata, Mihaela, Khurum Khan, David J. Collins, et al.. (2021). DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases. Cancer Imaging. 21(1). 67–67.
4.
Acar, Ahmet, Daniel Nichol, Javier Fernández-Mateos, et al.. (2020). Exploiting evolutionary steering to induce collateral drug sensitivity in cancer. Nature Communications. 11(1). 1923–1923.
5.
Khan, Khurum, Nicola Valeri, Sheela Rao, et al.. (2019). Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution. Critical Reviews in Oncology/Hematology. 143. 153–163.
6.
Khan, Khurum, Jayant K. Rane, David Cunningham, et al.. (2018). Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience. Clinical Colorectal Cancer. 18(1). 64–71.e1.
7.
Smyth, Elizabeth, Khurum Khan, & Nicola Valeri. (2018). Translational research and application of basic biology to clinical trial development in GI cancers. Annals of Translational Medicine. 6(9). 164–164.
8.
Khakoo, Shelize, Nicola Valeri, Thomas R. Jones, et al.. (2018). Circulating tumour DNA (ctDNA) as a tool to assess response and guide therapy adaptation in rectal cancer. Annals of Oncology. 29. viii661–viii661.
9.
Smyth, Elizabeth, Shenli Zhang, David Cunningham, et al.. (2017). Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy. Clinical Cancer Research. 23(24). 7543–7549.
10.
Fontana, Elisa, Chanthirika Ragulan, David Cunningham, et al.. (2017). Multiplatform assay to classify formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) samples into molecular subtypes with mutational profiles. Annals of Oncology. 28. v194–v194.
11.
Lote, Hazel, Domenico Zito, Rosemary Burke, et al.. (2016). MicroRNAs as biomarkers of resistance to HER2 inhibitors in combination with chemotherapy in gastro-oesophageal cancer cell lines. Annals of Oncology. 27. vi549–vi549.
12.
Smyth, Elizabeth, Matteo Fassan, David Cunningham, et al.. (2016). Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. Journal of Clinical Oncology. 34(23). 2721–2727.
13.
Sclafani, Francesco, Ian Chau, David Cunningham, et al.. (2016). KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial. Annals of Oncology. 27. vi173–vi173.
14.
Ghidini, Michele, Francesco Trevisani, Matteo Fassan, et al.. (2015). Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs). Annals of Oncology. 26. vi96–vi96.
15.
Fassan, Matteo, Luciano Cascione, Carlo Castoro, et al.. (2015). Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis. Oncotarget. 7(4). 4915–4924.
16.
Slattery, Martha L., Jennifer S. Herrick, Lila E. Mullany, et al.. (2014). An evaluation and replication of miRNA s with disease stage and colorectal cancer‐specific mortality. International Journal of Cancer. 137(2). 428–438.
17.
Ryan, Bríd M., Andrew C. McClary, Nicola Valeri, et al.. (2012). rs4919510 in hsa-mir-608 Is Associated with Outcome but Not Risk of Colorectal Cancer. PLoS ONE. 7(5). e36306–e36306.
18.
Voltan, Rebecca, Maria Grazia di Iasio, Raffaella Bosco, et al.. (2011). Nutlin-3 Downregulates the Expression of the Oncogene TCL1 in Primary B Chronic Lymphocytic Leukemic Cells. Clinical Cancer Research. 17(17). 5649–5655.
19.
Braconi, Chiara, Nicola Valeri, Pierluigi Gasparini, et al.. (2010). Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes. Clinical Cancer Research. 16(3). 957–966.
20.
Braconi, Chiara, R. Bracci, Italo Bearzi, et al.. (2008). KIT and PDGFRα mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. Annals of Oncology. 19(4). 706–710.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Chiara Braconi Breakdown of academic impact, for papers by Hideaki Bando Breakdown of academic impact, for papers by Philippe Tanière Breakdown of academic impact, for papers by Shunsuke Kato Breakdown of academic impact, for papers by Ryo Miyahara Breakdown of academic impact, for papers by Hitoshi Kawamata Breakdown of academic impact, for papers by Andreas Karameris Breakdown of academic impact, for papers by Seiji Satoh Breakdown of academic impact, for papers by Andrew Ruszkiewicz Breakdown of academic impact, for papers by Adam E. Frampton